Compare OKYO & VIVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OKYO | VIVO |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United Kingdom | United Kingdom |
| Employees | N/A | 41 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.7M | 80.1M |
| IPO Year | 2021 | N/A |
| Metric | OKYO | VIVO |
|---|---|---|
| Price | $1.58 | $5.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.33 | N/A |
| AVG Volume (30 Days) | 56.9K | ★ 1.9M |
| Earning Date | 07-18-2025 | 05-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.42 | $1.97 |
| 52 Week High | $3.35 | $6.86 |
| Indicator | OKYO | VIVO |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 55.90 |
| Support Level | $1.47 | $4.24 |
| Resistance Level | $1.73 | $6.86 |
| Average True Range (ATR) | 0.09 | 0.72 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 52.72 | 61.34 |
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
VivoPower PLC is engaged in building, owning, and leasing powered land and data center infrastructure for AI compute applications. The group delivers specialized infrastructure solutions across the AI Data Centers, Power-to-X, and Electric Mobility. It is develop and operated infrastructure that enables sovereign nations and institutional partners to secure control over power, data, and national intelligence, supporting AI, compute-intensive workloads, and energy transition use cases.